In most cases, these small cell neuroendocrine carcinomas are
associated with transitional cell carcinoma in-situ, and, sometimes, with
areas of squamous or glandular metaplasia so we would have been more consistent
if we had included this as one of the urothelial variants. However, there
was a conviction that this should be grouped with the non urothelial tumors
since it so completely dominates the behavior of the bladder tumor. They
do not differ from the pulmonary lesions in any way with respect to their
histological appearances or immunohistochemistry--some are "large cell"
neuroendocrine carcinomas, as in the lung. In the absence of CIS, one should
consider metastatic disease or extension of a small cell carcinoma from
the prostate [11,20,78,84,86].
|